Koeritz E. J., 146 Kolf-Clauw M., 46 Kolomiets T., 155, 156, 166, 174 Kolseth A.-K., 135, 157 Konieczny M., 181 Kovalenko E., 155, 156, 166, 174 Kovalsky-Paris M. P., 74 Kramer E., 235 Krnjaja V., 124, 142 Krska R., 39, 74, 136, 193, 232 Kugler K., 72, 136 Kuhnem P. R., 150 Kurleto D., 181 Kushalappa A. C., 69 Kwiatek M., 187 Lamprecht S. C., 152 Lancioni P., 105, 184, 188 Landschoot S., 75 Langin T., 73, 178 Längle T., 224 Lannou C., 164 Lantos C., 63 Lanubile A., 96, 196 Lanzanova C., 122, 197, 198 Larsen G., 54 Laurent B., 104 Laurent J., 41, 88 Laval V., 164 Lazzaro I., 96, 120 Lazzaroni N., 197 Leandro L. F., 53 Leblanc A., 42 Lecomte P., 73 Legoahec L., 106 Legrève A., 131, 216 Lehoczki-Krsjak S., 63, 173 Lemanceau P., 103 Lemmens M., 39, 66, 74, 136, 173, 231 Leplat J., 218 Leslie J. F., 50, 102 Lević J., 124, 142 Liénard C., 165 Lima A. M., 225 Limay-Rios V., 158, 205, 211 Lin Y. H., 202 Lippolis V., 184 Locatelli S., 122, 197, 198 Logrieco A., 171 Logrieco A. F., 85, 232 Lori G. A., 140, 145 Ludovici M., 38 Ługowska B., 187 Lysøe E., 59 Maccaferri M., 184 Madbouly A. K., 115 Maigniel J. P., 192 Malachova A., 39, 74 Malbrán I., 140, 145 Mangin P., 41, 218 Mankevičienė A., 123 Manners J., 27 Manstretta V., 51 Mantovani P., 188 Marcello A., 111, 137, 151 Marchegay G., 82 Marin P., 167 Marino M., 129 Marocco A., 96, 196 Martinez Tuppia C., 234 Martinez-Rocha A. L., 35 Mary M., 165 Mascher F., 79 Maschietto V., 196 Massi A., 105, 184 Matarese F., 83 Matysik P., 187 Maucourt M., 106 Maurer H.P., 68 Mayer K., 72 McLaren N. W., 210 Meddah B., 230 Méléard B., 191 Menke J., 40 Merhej J., 94 Mesterházy Á., 63, 173 Meyer T., 101 Mezaache-Aichour S., 223 Michel S., 68 Michlmayr H., 74 Miedaner T., 68 Migheli Q., 99, 111, 137, 140, 145, 151 Mikula H., 74, 193 Minenko E., 95 Mnari-Hattab M., 148 Moghtet S., 133, 230 Mohamed Nor N. M. I., 102 Moing A., 106 Moncini L., 83 Montanari M., 147 Montibus M., 33 Morales A. Z., 100 Moretti A., 44, 83, 170, 171, 232 Mostert G., 101 Mourelos C. A., 140, 145 Moussaoui A., 230 Muckle A., 175 Muehlbauer G., 74 Mulè G., 170, 232 Munaut F., 120, 142, 160, 165 Munkvold G. P., 53, 232 Münsterkötter M., 97 Musa T., 79 Nagavardhini A., 58 Nagl V., 39 Nahal Bouderba N., 133, 230 Nascimento S. B., 225 Nasraoui B., 208, 209 Ncube E., 227 Nesci A., 81, 221 Newmister S., 74 Nicolau M., 130, 214 Nicoli C. P., 150 Niehaus E. M., 45 Nielsen L. K., 116, 206 Niessen L., 95 Nipoti P., 98, 126, 222 Nordskog B., 77 Nussbaumer A., 80 Nussbaumer T., 72, 136 Obradović A., 124 Ochodzki P., 119, 153, 168, 181, 187 Oegema G., 235 Oliver S., 29 Opoku N., 190 Ostrowska A., 108 Oswald I. P., 43, 46 Pachetti G., 83 Pageau D., 212 Paizert K., 181 Pande S., 58 Pani G., 111 Pankratova L., 155, 156, 166, 174 Parent C., 212 Parikka P., 78, 86, 128, 180, 207 Pascale M., 184 Pasquali M., 99, 137 Pauk J., 63 Paulitz T., 209 Payne T., 65 Péan M., 43 Pereira P., 81 Perkowski J., 108, 118 Perochon A., 186 Persson P., 135, 157 Persson T., 213 Peters R. D., 158 Petrescu E., 200 Pettersson C. G., 213 Pfannmüller A., 37 Picot A., 82 Pilu R., 201 Pinson-Gadais L., 36, 82, 162, 163, 164, 233 Pisi A., 184 Pojmaj M., 181 Pons S., 82 239
Ponts N., 33, 36, 82, 94, 104, 106, 162 Portier L., 235 Preiser V., 136 Proctor R. H., 44 Prodi A., 126, 147, 184, 188 Prudente L., 171 Puel O., 43, 46 Purnhauser L., 63 Qi Y., 120, 160 Raaijmaakers J., 103 Rabeh Hajlaoui M., 148, 149 Rabie A. A., 101 Rämö S., 113, 127, 128, 207 Rampitsch C., 34 Rauvola M., 127 Ray R. V., 116, 182, 206 Rayment I., 74 Razzaghian J., 77 Redaelli R., 197, 198 Reis G. M., 110, 121 Reis S. P., 225 Ren C., 143 Renane R., 141 Renard F., 165 Renard M.-E., 216 Reverberi M., 38 Rezgui M., 209 Ricci A., 184 Richard-Forget F., 33, 36, 82, 94, 106, 162, 163, 233, 234 Riley H., 77 Rioux S., 212 Rispail N., 203 Rocha L. O., 110, 121 Rodriguez R., 219 Römpp A., 52 Rondags E., 107 Rose L. J., 101, 144, 152 Rösler S. M., 45 Rossi V., 51 Roucolle J., 82 Rubiales D., 203 Rubrycki K., 187 S. Rämö, 113, 127, 128, 207 Salleh B., 102 Salomoni D., 201 Sam E., 66, 136 Samad Zamini M., 66 Sarrocco S., 83 Sartori M., 81, 221 Satta B., 151 Sautour M., 88 Savard M., 143 Savelieva E. I., 109 240 Savoie J. M., 234 Sayah N., 223 Scala V., 38 Scauflaire J., 142, 160, 165 Schaafsma A., 175, 205, 211 Schäfer W., 32, 35 Scheeren P. L., 67 Scherm B., 99, 111, 137, 151 Schlang N., 65 Schmeitzl C., 231 Schneiderman D., 42, 100 Schoeters E., 47 Schuhmacher R., 39, 74, 193 Schwartz H., 39 Schweiger W., 61, 66, 72, 74, 194, 195 Seehusen T., 77 Sehabd A. F., 115 Selitskaya O. G., 109 Semaskiene R., 215 Shams M., 231 Shamshev I. V., 109 Sharma M., 58 Shin S., 74 Sibounnavong P., 228 Sieber C., 97 Siegel K., 103 Siegwart G., 66, 72, 136, 194, 195 Silva C. N., 150 Singh P. K., 65 Sixt N., 88 Sneller C., 64 Souza C. R. B., 225 Soytong K., 228 Spanu F., 99, 137 Sparkes D., 182 Sperschneider J., 27 Spolti P., 150 Spörhase P., 231 Stack J. P., 102 Stancic T., 189 Stanković S., 124, 142 Stea G., 44, 170, 171 Steen H. S, 77 Stefanelli S., 184 Steinberg C., 41, 88, 103, 218 Steiner B., 61, 66, 72, 178, 195 Stępień Ł., 112, 199 Strand E., 77 Strauss J., 136 Stuper K., 108, 118 Subramaniam G., 30, 34 Sudhadham M., 89 Sulyok M., 136, 232 Sundgren T. K., 77 Suproniene S., 215 Susca A., 44, 170, 171, 232 Sydenham S. L., 159, 185 Szabó-Hevér Á., 63, 173 Tadrist S., 43 Tallarico N., 47 Tamburic-Ilincic L., 62, 158, 175, 176 Tang D., 31, 93 Taylor J., 27 Techini F., 164 Tessmann D. J., 150 Teunckens A., 47 Thomas J., 161 Tibola C., 130 Tiilikkala K., 86 T<strong>of</strong>folatti S. L., 201 Tohno M., 125 Tonelli A., 105 Tonti S., 98, 126, 188 Toomajian C. P., 102 Topçu V., 172 Torres-Acosta J. A., 74, 231 Torri A., 197, 198 Toussaint J., 164 Trail F., 49 Tsukiboshi T., 125 Tuberosa R., 184 Tudzynski B., 37, 45, 97 Tunali B., 57, 167 Turtaut F., 82 Uegaki R., 125 Vachon E., 212 Valoti P., 197, 198 van Coller G. J., 144, 152 van den Berg J., 227 van den Top H., 235 van der Fels-Klerx H. J., 87 van der Lee T. A. J., 31, 44, 93, 114 van Diepeningen A. D., 89, 114, 236 Van Dyck S., 47 van Egmond H., 235 Van Hese V., 216 Van Hove F., 44, 120, 160 van Rensburg J. B. J., 227 Vanasse A., 212 Vanderborght T., 47 Vanheule A., 138 Vannacci G., 83 Varga E., 39 Varga M., 63, 173 Varraillon T., 80 Vennekens B., 47 Venturini G., 201
- Page 1 and 2:
Bordeaux EFS12 12 th European Fusar
- Page 4:
TABLE OF CONTENTS Welcome from the
- Page 7:
4 SPONSORSHIP The 12 th European Fu
- Page 11 and 12:
8 13:00 - 14:00 Lunch 14:00 - 15:00
- Page 13 and 14:
10 Session 4: Genetics of Hosts - P
- Page 15 and 16:
12 Thursday, May 16 th Session 6: F
- Page 17 and 18:
Evidence for birth-and-death evolut
- Page 19 and 20:
Future challenges of Fusarium and m
- Page 21 and 22:
P35 - Screening deoxynivalenol in o
- Page 23 and 24:
P76 - Fusarium verticillioides and
- Page 25 and 26:
P113 - Agronomic practices and risk
- Page 28:
ORAL PRESENTATIONS 25
- Page 32 and 33:
KEYNOTE LECTURE SESSION 1: FUSARIUM
- Page 34 and 35:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 36 and 37:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 38 and 39:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 40 and 41:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 42 and 43:
KEYNOTE LECTURE SESSION 2: SECONDAR
- Page 44 and 45:
SESSION 2: SECONDARY METABOLITES -
- Page 46 and 47:
SESSION 2: SECONDARY METABOLITES -
- Page 48 and 49:
SESSION 2: SECONDARY METABOLITES -
- Page 50:
SESSION 2: SECONDARY METABOLITES -
- Page 53 and 54:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 55 and 56:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 57 and 58:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 59 and 60:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 61 and 62:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 64 and 65:
KEYNOTE LECTURE 1 SESSION 4: GENETI
- Page 66 and 67:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 68 and 69:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 70 and 71:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 72 and 73:
KEYNOTE LECTURE 2 SESSION 4: GENETI
- Page 74 and 75:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 76 and 77:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 78 and 79:
KEYNOTE LECTURE SESSION 5: DISEASE
- Page 80 and 81:
SESSION 5: DISEASE CONTROL AND FORE
- Page 82 and 83:
SESSION 5: DISEASE CONTROL AND FORE
- Page 84 and 85:
SESSION 5: DISEASE CONTROL AND FORE
- Page 86:
SESSION 5: DISEASE CONTROL AND FORE
- Page 89 and 90:
SESSION 6: FUTURE CHALLENGE FOR EUR
- Page 91 and 92:
SESSION 6: FUTURE CHALLENGE FOR EUR
- Page 94:
POSTER PRESENTATIONS 91
- Page 97 and 98:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 99 and 100:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 101 and 102:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 103 and 104:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 105 and 106:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 107 and 108:
SESSION 1: FUSARIUM - GENETICS, GEN
- Page 109 and 110:
SESSION 2: SECONDARY METABOLITES -
- Page 111 and 112:
SESSION 2: SECONDARY METABOLITES -
- Page 113 and 114:
SESSION 2: SECONDARY METABOLITES -
- Page 115 and 116:
SESSION 2: SECONDARY METABOLITES -
- Page 117 and 118:
SESSION 2: SECONDARY METABOLITES -
- Page 119 and 120:
SESSION 2: SECONDARY METABOLITES -
- Page 121 and 122:
SESSION 2: SECONDARY METABOLITES -
- Page 123 and 124:
SESSION 2: SECONDARY METABOLITES -
- Page 125 and 126:
SESSION 2: SECONDARY METABOLITES -
- Page 127 and 128:
SESSION 2: SECONDARY METABOLITES -
- Page 129 and 130:
SESSION 2: SECONDARY METABOLITES -
- Page 131 and 132:
SESSION 2: SECONDARY METABOLITES -
- Page 133 and 134:
SESSION 2: SECONDARY METABOLITES -
- Page 135 and 136:
SESSION 2: SECONDARY METABOLITES -
- Page 137 and 138:
134
- Page 139 and 140:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 141 and 142:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 143 and 144:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 145 and 146:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 147 and 148:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 149 and 150:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 151 and 152:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 153 and 154:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 155 and 156:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 157 and 158:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 159 and 160:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 161 and 162:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 163 and 164:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 165 and 166:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 167 and 168:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 169 and 170:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 171 and 172:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 173 and 174:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 175 and 176:
SESSION 3: PATHOGENESIS - EPIDEMIOL
- Page 177 and 178:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 179 and 180:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 181 and 182:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 183 and 184:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 185 and 186:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 187 and 188:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 189 and 190:
SESSION 4: GENETICS OF HOSTS - PLAN
- Page 191 and 192: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 193 and 194: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 195 and 196: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 197 and 198: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 199 and 200: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 201 and 202: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 203 and 204: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 205 and 206: SESSION 4: GENETICS OF HOSTS - PLAN
- Page 207 and 208: 204
- Page 209 and 210: SESSION 5: DISEASE CONTROL AND FORE
- Page 211 and 212: SESSION 5: DISEASE CONTROL AND FORE
- Page 213 and 214: SESSION 5: DISEASE CONTROL AND FORE
- Page 215 and 216: SESSION 5: DISEASE CONTROL AND FORE
- Page 217 and 218: SESSION 5: DISEASE CONTROL AND FORE
- Page 219 and 220: SESSION 5: DISEASE CONTROL AND FORE
- Page 221 and 222: SESSION 5: DISEASE CONTROL AND FORE
- Page 223 and 224: SESSION 5: DISEASE CONTROL AND FORE
- Page 225 and 226: SESSION 5: DISEASE CONTROL AND FORE
- Page 227 and 228: SESSION 5: DISEASE CONTROL AND FORE
- Page 229 and 230: SESSION 5: DISEASE CONTROL AND FORE
- Page 231 and 232: SESSION 5: DISEASE CONTROL AND FORE
- Page 233 and 234: SESSION 6: FUTURE CHALLENGE FOR EUR
- Page 235 and 236: SESSION 6: FUTURE CHALLENGE FOR EUR
- Page 237 and 238: SESSION 6: FUTURE CHALLENGE FOR EUR
- Page 239 and 240: SESSION 6: FUTURE CHALLENGE FOR EUR
- Page 241: de Hoog G. S., 89, 114, 236 de Kler
- Page 245 and 246: 242
- Page 247 and 248: BOKU-University of Natural Resource
- Page 249 and 250: touatisihem03@yahoo.fr He Xinyao In
- Page 251 and 252: steve.oliver@bioc.cam.ac. uk Ortega
- Page 253 and 254: Subramaniam Gopal Agriculture and A